/Companies

Algenesis

San Diego, US · Delaware corporation · 10 known investors

Find your way into Algenesis

Sign up to see every warm intro you have to Algenesis

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Algenesis team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Algenesis Labs develops plant-based, biodegradable polyurethanes and polymers designed to replace petroleum-based materials while retaining durability. Its two chemical systems target manufacturers seeking non-toxic, compostable alternatives for their products.

Founders & leadership

DSDr. Stephen Mayfield
Dr. Stephen MayfieldFounder
DRDr. Robert Pomeroy
Dr. Robert PomeroyCo-founder
DMDr. Michael Burkart
Dr. Michael BurkartCo-founder
NS
Nicholas SandlandExecutive
PM
Peter MorganExecutive
TC
Thomas CookeExecutive

Board

WHWolfgang Hafenmayer
Wolfgang HafenmayerBoard MemberFounding Partner & Chief Investment Officer at Circulate Capital
VW
Veronica WuBoard directorGeneral Partner at First Bight Ventures
DR
Daniel RosenBoard director
DD
Daniel DearenBoard director

Investors · 10

Also in the syndicate · 3

Diamond Sports GroupMIH CapitalRhinoShield

Funding

SEC filings, press & company announcements

$16.2M disclosed across 5 rounds · 2021–2024

▶$3MraisedOct 2024 · 22 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wolfgang HafenmayerDirector
  • Nicholas SandlandExecutive Officer, Director
  • Veronica WuDirector
  • Daniel RosenDirector
  • Stephen MayfieldExecutive Officer, Director, Promoter
  • Daniel DearenDirector
Offering amount
$3M
Amount sold
$3M
First sale
Oct 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedDec 2023 · 25 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas CookeExecutive Officer, Director
  • Daniel DearenDirector
  • Peter MorganExecutive Officer, Promoter
  • Nancy DynanDirector
  • Robert PomeroyPromoter
  • Stephen MayfieldExecutive Officer, Director, Promoter
  • Michael BurkartPromoter
  • Daniel RosenDirector
Offering amount
$5M
Amount sold
$5M
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$847.1KraisedJul 2022 · 25 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael BurkartPromoter
  • Daniel DearenDirector
  • Nancy DynanDirector
  • Robert PomeroyPromoter
  • Daniel RosenDirector
  • Stephen MayfieldExecutive Officer, Director, Promoter
  • Thomas CookeExecutive Officer, Director
  • Peter MorganExecutive Officer, Promoter
Offering amount
$2M
Amount sold
$847.1K
First sale
May 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedApr 2021 · 48 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter MorganExecutive Officer, Promoter
  • Robert PomeroyPromoter
  • Stephen MayfieldExecutive Officer, Director, Promoter
  • Thomas CookeExecutive Officer, Director
  • Daniel RosenDirector
  • Daniel DearenDirector
  • Michael BurkartPromoter
Offering amount
$2.5M
Amount sold
$2.4M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Algenesis.

Non-dilutive funding · 6 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
Department of EnergyPhase II2023$1.1M
Department of EnergyPhase I2022$200K
Department of EnergyPhase II2020$1.1M
National Science FoundationPhase II2019$748.5K
Department of EnergyPhase I2019$199.9K
National Science FoundationPhase I2018$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Algenesis do?
Algenesis Labs develops plant-based, biodegradable polyurethanes and polymers designed to replace petroleum-based materials while retaining durability. Its two chemical systems target manufacturers seeking non-toxic, compostable alternatives for their products.
Who founded Algenesis?
Algenesis was founded by Dr. Stephen Mayfield, Dr. Robert Pomeroy, Dr. Michael Burkart.
Who are Algenesis's investors?
Algenesis's investors include Band of Angels, Circulate Capital, E8 Angels, Family Angel Management Fund, First Bight Ventures, Meliorate, Swan Venture Fund.
How much funding has Algenesis raised?
Algenesis has disclosed $16.2M raised across 5 rounds.
Where is Algenesis headquartered?
Algenesis is headquartered in San Diego, US.